Antioxidant and Antiradical Activity of Drugs Intended for Treating Ophthalmic Disorders


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Dosage forms intended for ophthalmic use with declared and potential antioxidant properties were investigated. Antioxidant activity was determined using potentiometry with potassium hexacyanoferrate (III) as the oxidant. Antiradical activity was studied using the stable radical 2,2-diphenyl-1-picrylhydrazyl. The reaction half-lives of the investigated dosage forms were determined. Ratios of the experimental antioxidant activity to the content of main active ingredient were assessed.

Авторлар туралы

A. Ivanova

Institute of Chemical Technology, B. N. Yeltsin Ural Federal University

Хат алмасуға жауапты Автор.
Email: a.v.ivanova@urfu.ru
Ресей, 19 Mir St., Ekaterinburg, 620002

E. Gerasimova

Institute of Chemical Technology, B. N. Yeltsin Ural Federal University

Email: a.v.ivanova@urfu.ru
Ресей, 19 Mir St., Ekaterinburg, 620002

E. Gazizullina

Institute of Chemical Technology, B. N. Yeltsin Ural Federal University

Email: a.v.ivanova@urfu.ru
Ресей, 19 Mir St., Ekaterinburg, 620002

Ya. Okulova

Institute of Chemical Technology, B. N. Yeltsin Ural Federal University

Email: a.v.ivanova@urfu.ru
Ресей, 19 Mir St., Ekaterinburg, 620002

A. Matern

Institute of Chemical Technology, B. N. Yeltsin Ural Federal University

Email: a.v.ivanova@urfu.ru
Ресей, 19 Mir St., Ekaterinburg, 620002

V. Rusinov

Institute of Chemical Technology, B. N. Yeltsin Ural Federal University

Email: a.v.ivanova@urfu.ru
Ресей, 19 Mir St., Ekaterinburg, 620002

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Springer Science+Business Media, LLC, part of Springer Nature, 2018